Our study further revealed that SIRT3 inhibition sensitized GBM cells to RSL3-induced ferroptosis by promoting mitophagy and reducing SLC7A11 expression (Fig. 10), providing insight into a potential combinatorial approach of targeting SIRT3 and inducing ferroptosis for GBM treatment. The gene discussed is SIRT3; the disease is glioblastoma.